Traws Pharma, Inc.TRAWNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank86
3Y CAGR+21.1%
5Y CAGR+12.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+21.1%/yr
vs +2.7%/yr prior
5Y CAGR
+12.5%/yr
Recent acceleration
Acceleration
+18.3pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$14.98M+21.9%
2024$12.29M+35.1%
2023$9.09M+7.7%
2022$8.45M-10.4%
2021$9.43M+13.2%
2020$8.33M-0.2%
2019$8.35M+10.0%
2018$7.59M+2.4%
2017$7.41M-18.5%
2016$9.08M-